2017 US Medicinal Products

Financial Strength Rankings using Artificial Intelligence

Top rated13 of 52
Best rating262 %
Worst rating-15,142 %
Negative Economic Capital Ratio27 of 52
Revenues25.6 B
Assets36.4 B
Expenses25.2 B
Stockholders Equity12.8 B
Unprofitable companies33 of 52

4. NEOGEN CORP

236.31%

6. INNOSPEC INC.

204.79%

9. HESKA CORP

162.00%

10. IMMUCELL CORP DE

160.50%

11. QUIDEL CORP DE

158.34%

12. FMC CORP

157.90%

13. KMG CHEMICALS INC

138.12%

14. FITLIFE BRANDS INC.

131.36%

15. BALCHEM CORP

115.80%

17. MANNATECH INC

82.57%

19. Ingevity Corp

39.79%

20. W R GRACE & CO

28.89%

21. OLIN Corp

28.00%

22. IMMUCOR INC

13.35%

24. CYANOTECH CORP

7.95%

25. Chemours Co

0.99%

27. OCI Partners LP

-6.25%

28. BIOMERICA INC

-11.21%

32. VOLITIONRX LTD

-178.61%

34. ARCA biopharma Inc.

-313.24%

38. Oncocyte Corp

-368.97%

40. IMMUNOMEDICS INC

-536.53%

42. Loop Industries Inc.

-560.58%

45. NUTRA PHARMA CORP

-771.47%

47. Target Group Inc.

-957.11%

48. TAURIGA SCIENCES INC.

-1119.80%

50. NEUTRA CORP.

-2970.39%

51. GL Brands Inc.

-7818.66%

United States Ratings

German Insurance Ratings